Divalproex Sodium
Product Images NDC 67296-1635

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 67296-1635). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Sdistributi19051016030 0001)

Label (Sdistributi19051016030 0001)
This is a description of a medication called Divalproex Sodium ER with a strength of 250mg. It is a prescription-only medication and comes in a pack of 10 tablets. The lot number is 12786A with an expiration date of 03/19. The usual adult dosage is mentioned but details can be found in the package insert. It should be stored at a controlled room temperature of 20-25 C (68-77 F). The medication is manufactured by Impax Generics in Hayward CA 94544 and distributed by Redpharm Drug in Eden Prairie MN 55344. The text also mentions a few other numbers that are not clear in meaning.*
FDA Label Image

Chemical Structure (Divalproex Sodium Extended Release Tablets 1)

FDA Label Image

Dvp Figure 1 (Divalproex Sodium Extended Release Tablets 2)

Dvp Figure 1 (Divalproex Sodium Extended Release Tablets 2)
This table appears to show the percentage reduction in CPS (Clinical Pain Score) rate for patients taking Divalproex Sodium delayed-release tablets compared to a placebo. The table also shows the corresponding improvement, no change, or worsening of the condition for patients. The percentages range from 100% reduction to 100% worsening. The % of patients is also shown on the bottom axis. Further context is needed to fully understand the purpose or implications of this data.*
FDA Label Image

Figure 2 (Divalproex Sodium Extended Release Tablets 3)

FDA Label Image

Figure 3 (Divalproex Sodium Extended Release Tablets 4)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.